~~<i id='273A820A08'><strike id='273A820A08'><tt id='273A820A08'><pre id='273A820A08'></pre></tt></strike></i>~~

Home» Wikipedia» Wikipedia

Wikipedia

author：hotspot 2025-09-29 03:43:09 Page View：1

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Readers respond to H5N1 and livestock movements, and more
Next article： Peter Hotez and the public health issue of online harassment

explore

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Data integrity in scientific journals requires "effort" by publishers, institutions

ScientificwatchdogsSholtoDavid(right)andElisabethBikjoinSTAT'sJonathenWosenattheSTATBreakthroughSumm

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

Addiction experts warn against a second 'war on drugs'

STAT'sLevFacher(left)spokewiththreeaddictionexperts—(fromleft)BraunzCourtney,KeithHumphreys,andAyesh